Novartis India Ltd. (NOVARTIND): Novartis India Share Price Hits Fresh 52-Week Low at Rs 1,609.85
- August 10, 2026
- Posted by: Harsh Piplani
- Category: News
Novartis India Share Price was at Rs 1,609.85 in early trade on 10 August 2026, down Rs 0.05 from the previous close of Rs 1,609.90, as the stock registered a fresh 52-week low. With a market capitalisation of Rs 3,974.97 crore, the move has brought Novartis India Ltd. into focus for investors tracking Stocks in News, Top Losers Today and fresh 52 Week Low Stocks across the Indian Stock Market.
The verified data confirms the price event, but it does not establish a company-specific catalyst behind why the stock is falling today. Even so, the one-year low matters because the day’s range was extremely narrow, with the stock opening at Rs 1,609.90, hitting a high of Rs 1,609.90 and a low of Rs 1,609.85. That places Novartis India Share Price Today right at its 52-week trough, making the stock relevant for market participants following price action, support behaviour and low-volume moves.
From a fundamental analysis perspective, Novartis India Share Price is currently associated with a P/E ratio of 9.36 and a P/B ratio of 6.44, while ROE stands at -1.29 and ROCE at -1.22. Those figures create a mixed picture: valuation multiples appear lower than the sector median on earnings, but return ratios are below the Trading sector benchmark. Univest notes that investors should monitor whether the stock continues to trade near its yearly low and how its valuation compares with peers and the broader sector.
Novartis India Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,609.85 |
| Previous Close | Rs 1,609.9 |
| Today's Change | Rs -0.05 (0%) |
| Day Open | Rs 1,609.9 |
| Fresh 52-Week Low | Rs 1,609.85 |
| Day High | Rs 1,609.9 |
| Current Volume | 16 |
| Turnover | Rs 0 crore |
| Market Capitalisation | Rs 3,974.97 crore |
Novartis India Ltd. (NOVARTIND) traded at Rs 1,609.85. versus the previous close of Rs 1,609.9, a rise of 0%. The stock opened at Rs 1,609.9, reached Rs 1,609.9, touched Rs 1,609.85. Reported volume was 16.
Novartis India Share Price Today shows a highly compressed trading session so far, with the stock opening at Rs 1,609.90, touching the same Rs 1,609.90 high, and slipping marginally to Rs 1,609.85, which is also the fresh 52-week low. The movement is small in absolute terms, but the one-year low is the headline event.
In plain terms, what happened today is straightforward. Novartis India Share Price began the session at the previous close level of Rs 1,609.90 and then edged lower by Rs 0.05 to Rs 1,609.85. The reported dayChangePercent is 0, indicating that the move is effectively flat on a percentage basis despite the absolute decline. Because the session low matches the 52-week low at Rs 1,609.85, the stock has entered fresh yearly-low territory.
Volume analysis also matters here. Only 16 shares had traded at the time of detection, while turnover was reported at Rs 0 crore. That suggests very light participation in this specific move. For traders and long-term trackers alike, such low Trading Volume means the event is notable as a screen-based price milestone, but the day’s price discovery has so far occurred on thin market participation rather than broad activity. In Share Market Today and Stock Market Today screens, that combination often places a stock in focus even without heavy turnover.
For Novartis India Stock News readers, the main takeaway is that the fresh 52-week trough is verified by the supplied data, but the move is not accompanied here by evidence of a broad-volume selloff. That distinction is important when assessing whether the current weakness reflects decisive Selling Pressure or simply a lightly traded mark-down. The next step is to test whether the valuation and profitability metrics add deeper context to this Novartis India Share Price Update.
Novartis India Ltd. (NOVARTIND) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 3,974.97 crore |
| P/E Ratio | 9.36x |
| P/B Ratio | 6.44x |
| ROE | -1.29% |
| ROCE | -1.22% |
Novartis India Ltd. was valued at a P/E ratio of 9.36x, a P/B ratio of 6.44x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of -1.29% and ROCE of -1.22%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Trading |
| Benchmark Scope | same sector |
| Company P/E Ratio | 9.36x |
| Benchmark Median P/E | 13.82x |
| Benchmark Average P/E | 88.67x |
| Benchmark P/E Range | 0x to 8,916.18x |
| Company P/B Ratio | 6.44x |
| Benchmark Median P/B | 1.29x |
| Company ROE | -1.29% |
| Benchmark Median ROE | 1.77% |
| Company ROCE | -1.22% |
| Benchmark Median ROCE | 3.71% |
| Company Market Capitalisation | Rs 3,974.97 crore |
| Benchmark Median Market Cap | Rs 42.88 crore |
Novartis India Ltd. (NOVARTIND) is classified under sector: Trading.
Novartis India Ltd. (NOVARTIND) has a P/E ratio of 9.36x, which is below the benchmark median of 13.82x, a difference of -32.27%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Novartis India Ltd. (NOVARTIND) has a ROE of -1.29%, which is below the benchmark median of 1.77%, a difference of -172.88%. Novartis India Ltd. (NOVARTIND) has a ROCE of -1.22%, which is below the benchmark median of 3.71%, a difference of -132.88%.
Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Elitecon International Ltd. | ELITECON | 2,893.28 | 9.36 | 6.44 | -1.29 | -1.22 |
| Confidence Petroleum India Ltd. | CONFIPET | 2,702.45 | 29.09 | 1.91 | 9.89 | 12.79 |
| SIRCA Paints India Ltd. | SIRCA | 2,557.1 | 38.15 | 5.2 | 12.99 | 17.3 |
| Fischer Medical Ventures Ltd. | FISCHER | 2,491.09 | 80.31 | 6.94 | 0 | -11.19 |
| Vintage Coffee & Beverages Ltd. | VINCOFE | 2,172.42 | 27.59 | 3.78 | 3.02 | 4.38 |
Novartis India Ltd. (NOVARTIND) has a P/E ratio of 9.36x compared with the displayed peer median of 29.09x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -1.29% compares with a peer median of 3.02% across the companies shown in the table. ROCE stood at -1.22% versus the displayed peer median of 4.38%, providing a capital-efficiency comparison. Novartis India Ltd. (NOVARTIND) has a market capitalisation of Rs 3,974.97 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Why Investors Are Watching Novartis India
This stock is drawing attention because the fresh one-year low comes with a distinct mix of price action, valuation and sector positioning. The verified data offers several reasons why Novartis India Share Price is on investor watchlists today.
- Fresh 52-week low: Novartis India Share Price touched Rs 1,609.85, exactly matching the new 52-week trough.
- Flat but negative session: The stock was down Rs 0.05 from the previous close of Rs 1,609.90, with dayChangePercent shown as 0.
- Narrow intraday range: Open and high were both Rs 1,609.90, while the day low was Rs 1,609.85, highlighting compressed Price Action.
- Light participation: Current volume was only 16 shares and turnover stood at Rs 0 crore, indicating limited trading activity so far.
- Valuation contrast: The P/E of 9.36 is below the sector median of 13.82, while the P/B of 6.44 is above the sector median of 1.29.
- Profitability pressure: ROE of -1.29 and ROCE of -1.22 are both below the relevant sector medians and averages.
- Peer context: Market cap of Rs 3,974.97 crore is above the five supplied peers, but returns lag several of them.
About Novartis India
Novartis India Ltd. is the listed company tracked under the symbol NOVARTIND. In the supplied market dataset used for this article, the company is classified within the Trading sector. That sector tag is the basis for the benchmark comparison used throughout this Novartis India Fundamental Analysis and sector review.
Based on the verified figures available here, Novartis India is currently valued by the market at Rs 3,974.97 crore and is being compared against a same-sector universe of 456 companies. The stock is also being tracked against listed peers such as Elitecon International, Confidence Petroleum India, SIRCA Paints India, Fischer Medical Ventures and Vintage Coffee & Beverages for relative valuation and return analysis.
Because this article relies only on supplied verified data, the company context is intentionally focused on market classification, peer set and current stock positioning rather than unsupported business descriptions. For investors following Novartis India Latest News, the most relevant takeaway today is how the company is being priced by the market within its Trading-sector benchmark after falling to a fresh 52-week low.
Track Novartis India Share Price on Univest
Use Novartis India Ltd. (NOVARTIND) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.
Investors tracking Novartis India Share Price can use Univest to follow live share price moves, 52-week levels, market capitalisation, valuation ratios, peer comparison and broader market insights. For stocks making fresh yearly lows, these data points help separate a simple screen event from a more meaningful shift in market positioning.
On Univest, users can monitor Novartis India Share Price Today alongside metrics such as P/E, P/B, ROE, ROCE, peer statistics and sector benchmarks. The platform is also useful for following Novartis India Stock News, Novartis India Shareholding Pattern when available, and future Share Price Update signals as the stock trades around important 52-week levels. For investors watching NSE News, BSE News and Market Movers, keeping the stock on a live dashboard can provide better context than a single-day move alone.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is Novartis India Share Price in focus today?
Ans. Novartis India Share Price is in focus because it touched a fresh 52-week low of Rs 1,609.85 on 10 August 2026. The stock was marginally below the previous close of Rs 1,609.90, bringing the one-year low into clear market focus.
What is Novartis India Share Price Today?
Ans. Novartis India Share Price Today was Rs 1,609.85 at the time of the event. The stock opened at Rs 1,609.90, reached a day high of Rs 1,609.90, and slipped to a day low of Rs 1,609.85.
How much did Novartis India stock fall today?
Ans. The stock fell by Rs 0.05 compared with the previous close of Rs 1,609.90. The supplied dayChangePercent is 0, which indicates the move is negligible in percentage terms despite the fresh 52-week low event.
What is the new 52-week low of Novartis India?
Ans. The new 52-week low of Novartis India is Rs 1,609.85. That level was also the intraday low during the reported session, confirming that Novartis India Share Price entered fresh yearly-low territory on the supplied data.
What does today’s volume indicate for Novartis India Share Price?
Ans. The current volume was only 16 shares, while turnover stood at Rs 0 crore at the time of detection. That suggests the fresh 52-week low occurred on very light trading participation rather than on broad market activity.
What is the market capitalisation of Novartis India?
Ans. Novartis India has a market capitalisation of Rs 3,974.97 crore. In the supplied Trading-sector benchmark of 456 companies, that is far above the median market cap of Rs 42.88 crore but below the average of Rs 21,840.15 crore.
Is Novartis India cheap on valuation compared with its sector?
Ans. On earnings, Novartis India looks lower than the sector median because its P/E is 9.36 versus 13.82. However, its P/B is 6.44 against a sector median of 1.29, so the valuation picture is mixed rather than one-sided.
How profitable is Novartis India compared with the sector benchmark?
Ans. The supplied profitability ratios are weaker than the benchmark. Novartis India reports ROE of -1.29 and ROCE of -1.22, while the sector medians are 1.77 and 3.71 respectively, indicating lower return efficiency than the benchmark.
How does Novartis India compare with key peers?
Ans. Novartis India has a higher market cap than the five supplied peers, at Rs 3,974.97 crore. Its P/E of 9.36 is below most peers, but its ROE of -1.29 and ROCE of -1.22 lag several comparables.
What should investors monitor next in Novartis India Share News?
Ans. Investors can monitor whether Novartis India Share Price continues to trade near Rs 1,609.85, whether volume remains light, and how the stock’s P/E of 9.36 and negative return ratios compare with peers and the Trading-sector benchmark.
